May & Baker, a manufacturer, and distributor of pharmaceutical products in its recently released nine-month financial results for the period ended September 2022 has reported a 62…
For the business year ended December 31, 2021, May &Baker Nigeria Plc, a leading drug manufacturer grew its revenue by 27percent to N11.9billion from N9.4 billion recorded in the…
Nigeria’s leading pharmaceutical company, May & Baker Nigeria Plc recorded impressive performance in the third quarter (Q3) as improving sales combined with increasingly efficient…
In our last coverage of drug maker, May & Baker plc, “Sustaining the path of profitability amid economic headwinds, cashstrapped consumers” we highlighted some challenges facing…
In our last coverage of drug maker, May & Baker plc, “Sustaining the path of profitability amid economic headwinds, cash-strapped consumers”we highlighted some challenges facing…